BOTHELL, Wash., Jan. 5 /PRNewswire-FirstCall/ -- Cardiac Science
Corporation (Nasdaq: CSCX), a global leader in advanced cardiac monitoring and
defibrillation products, announced today that Michael Matysik, chief financial
officer, will speak at the eighth annual Needham & Company Growth Conference
on Tuesday, January 10, 2006, at 2:30 P.M. (Eastern Time). The conference is
being held at the New York Palace Hotel from January 10-13, 2006.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO )
Mr. Matysik will be discussing recent business highlights and related
financial information regarding Cardiac Science Corporation. The presentation
will be web cast live and will be available over the Internet at
http://www.cardiacscience.com.
About Cardiac Science Corporation
Cardiac Science Corporation develops, manufactures, and markets a family
of advanced diagnostic and therapeutic cardiology devices and systems,
including automated external defibrillators, electrocardiographs, stress test
systems, Holter monitoring systems, hospital defibrillators, cardiac
rehabilitation telemetry systems, patient monitor -- defibrillators and
cardiology data management systems. Cardiac Science Corporation also sells a
variety of related products and consumables, and provides a comprehensive
portfolio of training, maintenance and support services.
The company is the successor to various entities that have owned and
operated cardiology related businesses, which sold products under the trusted
brand names Burdick(R), Powerheart(R), and Quinton(R). Cardiac Science
Corporation is headquartered in Bothell, WA, and also has operations in Lake
Forest, California; Deerfield, Wisconsin; Shanghai, China; Copenhagen, Denmark
and Manchester, United Kingdom.
Contact:
Mike Matysik
Senior vice president and chief financial officer
425-402-2009
SOURCE Cardiac Science Corporation
back to top
